Frontiers in Oncology | Pharmacology of Anti-Cancer Drugs

Correction

Published on 01 Oct 2025

Correction: Chorordin-like 1 inhibits pancreatic cancer cell migration and invasion: involvement of the BMP4/SMAD pathway

in Pharmacology of Anti-Cancer Drugs

Wei Li
Yalan Zhong
Yuqiao Song
Hongmei Wang
Zheng Jiang

Frontiers in Oncology

doi 10.3389/fonc.2025.1705973

716 views

Case Report

Accepted on 30 Sep 2025

A case report of malignant hypertension and multiorgan dysfunction during immunotherapy for gallbladder cancer

in Pharmacology of Anti-Cancer Drugs

Caroline Anthon
Hugo Pierret
Frederic Houssiau
Astrid De Cuyper
Cédric Van Marcke
Marc Van Den Eynde
Filomena Mazzeo
Frank Cornelis
Rachel Galot
Francois P Duhoux

Frontiers in Oncology

doi 10.3389/fonc.2025.1658621

Systematic Review

Accepted on 30 Sep 2025

Evaluating the efficacy and safety of tebentafusp in the treatment of metastatic uveal melanoma: A 2025 update systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Yanlin Wang
Wen Sun
Bing Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1667282

Editorial

Accepted on 29 Sep 2025

Editorial: Novel Therapeutic Strategies for Pancreatic Cancer: From Mechanisms to Clinical Translation

in Pharmacology of Anti-Cancer Drugs

XIAO SUN
XU Hong De

Frontiers in Oncology

doi 10.3389/fonc.2025.1705678

278 views

Correction

Published on 29 Sep 2025

Correction: Integrating network pharmacology and transcriptomics to identify solasonine’s anti-osteosarcoma targets and experimental validation

in Pharmacology of Anti-Cancer Drugs

Daihao Wei
Minyu Li
Dawei Chu
Jiandang Shi

Frontiers in Oncology

doi 10.3389/fonc.2025.1682157

549 views

Review

Accepted on 26 Sep 2025

Overcoming Cancer Drug Resistance: Insights into Apoptotic Pathway Modulation by Plant based Nanoparticle and Natural Products

in Pharmacology of Anti-Cancer Drugs

Amit Kumar Singh
Prem Prakash Kushwaha
Ajaya Kumar Singh
Abhay K. Pandey

Frontiers in Oncology

doi 10.3389/fonc.2025.1677380

424 views

Original Research

Published on 26 Sep 2025

Andrographolide suppresses chondrosarcoma cell migration and invasion by inhibiting the PI3K/Akt/mTOR signaling pathway and activating autophagy

in Pharmacology of Anti-Cancer Drugs

Chun-Fei Wu
Li-xin Ouyang
Wan-hao Zhang
Shuo Yang
Xian-Xing Zhong
Yong Lin
Shuai Fan
Peng Li
Zu-Jian Liang

Frontiers in Oncology

doi 10.3389/fonc.2025.1622666

1,677 views

Data Report

Published on 25 Sep 2025

An analysis of FDA drug approvals for oncological hematological malignancies in relation to companion diagnostics

in Pharmacology of Anti-Cancer Drugs

Jan Trøst Jørgensen

Frontiers in Oncology

doi 10.3389/fonc.2025.1635491

1,803 views

Case Report

Accepted on 24 Sep 2025

Case Report: Bevacizumab-Induced Renal-limited TMA and FSGS-like lesions in a Kidney Transplant Recipient

in Pharmacology of Anti-Cancer Drugs

Xingxing Jian
Ge Liu
Shuangyan Yu
Jie Sheng

Frontiers in Oncology

doi 10.3389/fonc.2025.1638274

295 views

Editorial

Published on 24 Sep 2025

Editorial: Head and neck squamous cell carcinoma: navigating the dawn of personalized medicine

in Pharmacology of Anti-Cancer Drugs

Luis Abel Quiñones
Ye Guo
Fujun Han

Frontiers in Oncology

doi 10.3389/fonc.2025.1684617

998 views

Editorial

Published on 24 Sep 2025

Editorial: Immune checkpoints regulatory mechanisms and immunotherapy strategies in gastrointestinal tumors

in Pharmacology of Anti-Cancer Drugs

Qing Xi
Rongxin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1697974

1,245 views

Review

Accepted on 22 Sep 2025

The Role of Cytostatic in Oxidative Stress Reactions

in Pharmacology of Anti-Cancer Drugs

Renata Polaniak
Aleksander Kwiatkowski
Michał Górski
Elżbieta Grochowska-Niedworok
Małgorzata Latocha

Frontiers in Oncology

doi 10.3389/fonc.2025.1667522

275 views

Review

Published on 17 Sep 2025

Recombinant human adenovirus type 5 administration for the treatment of malignant ascites or pleural effusion in cancer patients: a meta-analysis

in Pharmacology of Anti-Cancer Drugs

Changsong Duan
Xue Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1592995

782 views

Original Research

Published on 05 Sep 2025

Osthole suppresses prostate cancer progression by modulating PRLR and the JAK2/STAT3 signaling axis

in Pharmacology of Anti-Cancer Drugs

Linjun Yan
Jiaqi Mei
Yuanqiao He
Qi Cui
Xiaohong Wang
Feng Lv
Keyue Cao
Yuanjian Shao

Frontiers in Oncology

doi 10.3389/fonc.2025.1630181

925 views

Original Research

Published on 03 Sep 2025

Oleanolic acid alleviates ovarian cancer by regulating the miR-122/PDK4 axis to induce autophagy and inhibit glycolysis in vivo and in vitro

in Pharmacology of Anti-Cancer Drugs

Zhen Zeng
Qing Lin
Jing Yu
Min Lin
Ningwei Zhao

Frontiers in Oncology

doi 10.3389/fonc.2025.1670758

1,194 views

Original Research

Published on 01 Sep 2025

Effects of parthenolide on amino acid metabolism and oxidative stress in lung adenocarcinoma based on quantitative proteomic analysis, targeted amino acid metabolomics, network pharmacology, and experimental validation

in Pharmacology of Anti-Cancer Drugs

Jiye Liu
Yu Liu
Jiachun Li
Shuang Shen

Frontiers in Oncology

doi 10.3389/fonc.2025.1642866

964 views